Abdulrahman Nasiri: Bone Marrow Biopsy Safety on Anticoagulation
Abdulrahman Nasiri, Hematologist, Assistant Professor at Imam Muhammad ibn Saud Islamic University, posted on LinkedIn:
”Honored to be participating in the MENA Hematology Congress 2025 held in Al-Madinah, where I presented our paper titled:
Safety of Bone Marrow Biopsy in Patients Receiving Anticoagulation Therapy
A Systematic Review and Meta-Analysis
This work reviewed more than 65,000 bone marrow biopsy procedures, including over 1,000 anticoagulated patients. The analysis showed that bone marrow biopsy maintains an excellent safety profile, even in patients on anticoagulation, and highlighted the patient-specific factors that truly influence bleeding risk.
Grateful for the opportunity to share this research among distinguished hematologists and researchers across the region.
The congress is still ongoing, and I look forward to the remaining sessions and discussions.
My appreciation to the organizers for a well-executed scientific meeting and to colleagues who enriched the exchange with their insights.”
Stay updated with Hemostasis Today.
-
Mar 8, 2026, 16:19Simon Senanu: Crossmatch Procedures and Advanced Troubleshooting
-
Mar 8, 2026, 15:53Stuart Diamond: ApoB as a Key Marker of Cardiovascular Risk
-
Mar 8, 2026, 15:49Wolfgang Miesbach: Discussing Immunological Challenges in Hemophilia at GTH 2026
-
Mar 8, 2026, 15:41George Sands: AI Screening Tool for Early Detection of Heart Disease
-
Mar 8, 2026, 15:26Hussien Hishmat: The 2026 Guide to Pulmonary Embolism – Diagnosis Decoded
-
Mar 8, 2026, 15:01Raluca Simbotin: How We Care for Complex Patients Is A Measure of Healthcare System Maturity
-
Mar 8, 2026, 14:09Frederik Denorme։ PhD Position in Translational Stroke Research at the University of Antwerp
-
Mar 8, 2026, 14:03Akinchan Bhardwaj: Will Plaque Imaging Eventually Reshape Preventive Cardiology Workflows?
-
Mar 8, 2026, 14:00Hisam Siddiqi: A Helpful Clinical Framework for Understanding Eosinophilia